| Popis: |
Coronavirus (COVID-19) pandemic incidences of deep vein thrombosis (DVT) have been reported in considerable figures. This research aimed to assess the incidence of deep vein thrombosis (DVT) in COVID-19 patients admitted to De Martini Hospital Mogadishu, Somalia assigned for COVID-19 isolation cases. Method: All patients diagnosed with COVID-19 and performed venous ultrasounds by the radiology department between February 10 and April 10, 2021, in De-Martini hospital were enrolled. A retrospective data collected the demographic information and the participants' required clinical history, investigations, and treatment records. The study's primary step was the incidence of DVT in the in-hospital COVID-19 cases and its association with clinical and laboratory risk factors. Result: One hundred thirty-eight patients (Mean age was 62.58±13.12 years, 30.6% female, 56 ICU) participated in the study. More than 90% of the patients had at least one risk factor, and hypertension was the most prevalent condition (27.3%). While 39.9% were diagnosed with Deep Venous Thrombosis (DVT) after venous Doppler ultrasonography. Over 69.1% (38 patients) of the DVT group patients had lower extremity type, but 30.9% (17 patients) of the DVT patients had Upper extremity type. 78.9% (43 patients) of the DVT group were ICU patients, and 21.1% (12 patients) were admitted to the ward. Total ICU cases for advanced treatment were 55% patients. The DVT rate was higher in ICU (84%) than in Ward patients (16%). For 76 (55.1%) of the patients were admitted to the ICU for further care and the ICU patients in DVT group were significantly more than non-DVT group (85.0% vs 36.1%, P=0.002). Heart rate, respiratory rate, oxygen saturation, white blood counts, D-dimer, CRP, and Anticoagulation use had significant statistical difference since P-value is less than 0.05 Conclusion: Approximately, 39.9% incidence of DVT in COVID19 is remarkably high, which can lead to high morbidity and mortality. Our findings suggest early screening of DVT and therapeutic anticoagulation of COVID-19 cases, especially ICU-admitted patients. Also, further research is required for identification of DVT risk factors in COVID-19 patients. |
